145 related articles for article (PubMed ID: 28074935)
1. Neutrophil elastase cleavage of the gC1q domain impairs the EMILIN1-α4β1 integrin interaction, cell adhesion and anti-proliferative activity.
Maiorani O; Pivetta E; Capuano A; Modica TM; Wassermann B; Bucciotti F; Colombatti A; Doliana R; Spessotto P
Sci Rep; 2017 Jan; 7():39974. PubMed ID: 28074935
[TBL] [Abstract][Full Text] [Related]
2. The α4β1/EMILIN1 interaction discloses a novel and unique integrin-ligand type of engagement.
Capuano A; Fogolari F; Bucciotti F; Spessotto P; Nicolosi PA; Mucignat MT; Cervi M; Esposito G; Colombatti A; Doliana R
Matrix Biol; 2018 Mar; 66():50-66. PubMed ID: 29037761
[TBL] [Abstract][Full Text] [Related]
3. The solution structure of EMILIN1 globular C1q domain reveals a disordered insertion necessary for interaction with the alpha4beta1 integrin.
Verdone G; Doliana R; Corazza A; Colebrooke SA; Spessotto P; Bot S; Bucciotti F; Capuano A; Silvestri A; Viglino P; Campbell ID; Colombatti A; Esposito G
J Biol Chem; 2008 Jul; 283(27):18947-56. PubMed ID: 18463100
[TBL] [Abstract][Full Text] [Related]
4. The extracellular matrix protein EMILIN1 silences the RAS-ERK pathway via α4β1 integrin and decreases tumor cell growth.
Modica TME; Maiorani O; Sartori G; Pivetta E; Doliana R; Capuano A; Colombatti A; Spessotto P
Oncotarget; 2017 Apr; 8(16):27034-27046. PubMed ID: 28177903
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase-dependent cleavage compromises the tumor suppressor role of EMILIN1.
Pivetta E; Danussi C; Wassermann B; Modica TM; Del Bel Belluz L; Canzonieri V; Colombatti A; Spessotto P
Matrix Biol; 2014 Feb; 34():22-32. PubMed ID: 24513040
[TBL] [Abstract][Full Text] [Related]
6. EMILIN1 represents a major stromal element determining human trophoblast invasion of the uterine wall.
Spessotto P; Bulla R; Danussi C; Radillo O; Cervi M; Monami G; Bossi F; Tedesco F; Doliana R; Colombatti A
J Cell Sci; 2006 Nov; 119(Pt 21):4574-84. PubMed ID: 17074837
[TBL] [Abstract][Full Text] [Related]
7. A 17-residue sequence from the matrix metalloproteinase-9 (MMP-9) hemopexin domain binds α4β1 integrin and inhibits MMP-9-induced functions in chronic lymphocytic leukemia B cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Vituri CL; del Cerro MH; Terol MJ; Albar JP; Rivas G; García-Marco JA; García-Pardo A
J Biol Chem; 2012 Aug; 287(33):27601-13. PubMed ID: 22730324
[TBL] [Abstract][Full Text] [Related]
8. The EMILIN/Multimerin family.
Colombatti A; Spessotto P; Doliana R; Mongiat M; Bressan GM; Esposito G
Front Immunol; 2011; 2():93. PubMed ID: 22566882
[TBL] [Abstract][Full Text] [Related]
9. EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation.
Danussi C; Petrucco A; Wassermann B; Pivetta E; Modica TM; Del Bel Belluz L; Colombatti A; Spessotto P
J Cell Biol; 2011 Oct; 195(1):131-45. PubMed ID: 21949412
[TBL] [Abstract][Full Text] [Related]
10. Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains.
Bot S; Andreuzzi E; Capuano A; Schiavinato A; Colombatti A; Doliana R
Matrix Biol; 2015 Jan; 41():44-55. PubMed ID: 25445627
[TBL] [Abstract][Full Text] [Related]
11. Alpha4beta1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells.
Redondo-Muñoz J; Ugarte-Berzal E; García-Marco JA; del Cerro MH; Van den Steen PE; Opdenakker G; Terol MJ; García-Pardo A
Blood; 2008 Jul; 112(1):169-78. PubMed ID: 18326820
[TBL] [Abstract][Full Text] [Related]
12. Integrin binding site within the gC1q domain orchestrates EMILIN-1-induced lymphangiogenesis.
Capuano A; Pivetta E; Baldissera F; Bosisio G; Wassermann B; Bucciotti F; Colombatti A; Sabatelli P; Doliana R; Spessotto P
Matrix Biol; 2019 Aug; 81():34-49. PubMed ID: 30408617
[TBL] [Abstract][Full Text] [Related]
13. ADAM disintegrin-like domain recognition by the lymphocyte integrins alpha4beta1 and alpha4beta7.
Bridges LC; Sheppard D; Bowditch RD
Biochem J; 2005 Apr; 387(Pt 1):101-8. PubMed ID: 15504110
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha4beta1-dependent adhesion to ADAM 28 (MDC-L) requires an extended surface of the disintegrin domain.
Bridges LC; Hanson KR; Tani PH; Mather T; Bowditch RD
Biochemistry; 2003 Apr; 42(13):3734-41. PubMed ID: 12667064
[TBL] [Abstract][Full Text] [Related]
15. Contrasting roles for domain 4 of VCAM-1 in the regulation of cell adhesion and soluble VCAM-1 binding to integrin alpha4beta1.
Woodside DG; Kram RM; Mitchell JS; Belsom T; Billard MJ; McIntyre BW; Vanderslice P
J Immunol; 2006 Apr; 176(8):5041-9. PubMed ID: 16585601
[TBL] [Abstract][Full Text] [Related]
16. A novel CD44-binding peptide from the pro-matrix metalloproteinase-9 hemopexin domain impairs adhesion and migration of chronic lymphocytic leukemia (CLL) cells.
Ugarte-Berzal E; Bailón E; Amigo-Jiménez I; Albar JP; García-Marco JA; García-Pardo A
J Biol Chem; 2014 May; 289(22):15340-9. PubMed ID: 24739387
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Hemopexin-like Domain of Latent Matrix Metalloproteinase-9 (proMMP-9) with a Small Molecule Inhibitor Prevents the Formation of Focal Adhesion Junctions.
Alford VM; Kamath A; Ren X; Kumar K; Gan Q; Awwa M; Tong M; Seeliger MA; Cao J; Ojima I; Sampson NS
ACS Chem Biol; 2017 Nov; 12(11):2788-2803. PubMed ID: 28945333
[TBL] [Abstract][Full Text] [Related]
18. Single residue determines the specificity of neutrophil elastase for Shigella virulence factors.
Averhoff P; Kolbe M; Zychlinsky A; Weinrauch Y
J Mol Biol; 2008 Apr; 377(4):1053-66. PubMed ID: 18295791
[TBL] [Abstract][Full Text] [Related]
19. Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.
Pivetta E; Wassermann B; Del Bel Belluz L; Danussi C; Modica TM; Maiorani O; Bosisio G; Boccardo F; Canzonieri V; Colombatti A; Spessotto P
Clin Sci (Lond); 2016 Jul; 130(14):1221-36. PubMed ID: 26920215
[TBL] [Abstract][Full Text] [Related]
20. NMR-based homology model for the solution structure of the C-terminal globular domain of EMILIN1.
Verdone G; Corazza A; Colebrooke SA; Cicero D; Eliseo T; Boyd J; Doliana R; Fogolari F; Viglino P; Colombatti A; Campbell ID; Esposito G
J Biomol NMR; 2009 Feb; 43(2):79-96. PubMed ID: 19023665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
